Subhash Sinha, | 2020

Virtual High-Throughput Screening for CD33 Inhibitors

Qisheng Zhang, John Sondek, Kenneth Pearce, | 2020

Small Molecule Activators of PLC-gamma-2 as Novel Therapeutics for Alzheimer’s Disease

Gilbert Gallardo, | 2020

Investigating the Contribution of Astrocytic-Dependent Inflammation on Amyloid-Induced Tau Pathology

Stephen Wong, | 2020

Uncovering the Molecular Mechanisms of Selected Drug Candidates Derived from Systematic Alzheimer’s Drug Repositioning

Weiming Xia, | 2020

Proteomics of Alzheimer’s Disease Three-Dimensional Cultures

George S. Bloom, Elizabeth R. Sharlow, John S. Lazo, | 2020

Adult Human iNeurons: A Next-Generation Drug Screening Platform for Alzheimer’s Disease

Mathew Blurton-Jones, | 2020

Neuroinflammation Consortium: Examining the Role of Human Microglia in the Transition Between Parenchymal and Vascular Amyloid Beta Pathology

Maarten Dewilde, Bart De Strooper, | 2020

Novel Entry Routes for Therapeutic Biologicals to the Brain

Deepak Kumar Vijaya Kumar, Nanda Kumar Navalpur Shanmugam, Rudolph Tanzi, William Eimer, | 2020

Characterizing Gut Microbiome Synergy With Emphasis on Mycobiome and Its Impact on Alzheimer’s Disease (AD) Pathology in AD Mouse Models

Doo Yeon Kim, Luisa Quinti, | 2020

High-Throughput Drug Screening for Alzheimer’s Disease Using Three-Dimensional Human Neural Culture Systems

Ana Griciuc, | 2020

Modulating CD33 Function and Neuroinflammation as a Therapeutic Approach for Alzheimer’s Disease

Liisa Galea, | 2020

Sex Matters: Understanding the Influence of Sex and Apolipoprotein E (APOE) Genotype on Hippocampal Plasticity and Cognition